Skip to main content
Equibles

ARGX · Argenx SE · Investor Relations

Track ARGX — free

Use ARGX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ARGX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$960.04 -21.29 (-2.17%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$60.37B
Shares
62.89M
Volume · Nov 13 226.16K Avg daily vol (3M) 365.92K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-17 00:00 UTC argenx to Present at Jefferies Global Healthcare Conference Conference

Recent news

Date Headline
2026-10-22 argenx Reports Third Quarter 2026 Financial Results and Provides Business Update

Past events

Date Event Type
2026-11-10 argenx to Present at Guggenheim 3rd Annual Healthcare Innovation Conference Conference
2026-10-22 Q3 FY2026 Earnings conference call (announced in 6-K) Earnings call
2026-09-14 argenx to Present at Morgan Stanley 24th Annual Global Healthcare Conference Conference
2026-09-08 argenx to Present at Wells Fargo 21st Annual Healthcare Conference Conference
2026-09-01 argenx to Present at Wells Fargo 21st Annual Healthcare Conference Conference
2026-09-01 argenx to Present at Morgan Stanley 24th Annual Global Healthcare Conference Conference
2026-08-17 ALKIVIA Study Topline Results Event
2026-07-27 argenx Business Update Event
2026-07-23 Q2 FY2026 Earnings conference call (announced in 6-K) Earnings call
2026-07-23 Half Year 2026 Financial Results and Second Quarter Business Update Results publication
2026-06-23 R&D Spotlight: Advancing FcRn Leadership into Autoimmune Myositis Event
2026-06-09 argenx to Present at Goldman Sachs 47th Annual Global Healthcare Conference Conference
2026-06-03 argenx to Present at William Blair 46th Annual Growth Stock Conference Conference
2026-05-12 argenx to Present at BofA Securities 2026 Health Care Conference Conference
2026-05-07 First Quarter 2026 Financial Results and Business Update Results publication
2026-03-02 TD Cowen 46th Annual Health Care Conference Conference
2026-02-26 Earnings conference call (announced in 6-K) Earnings call

Source: https://argenx.com/investors

Key facts CIK 1697862 CUSIP 04016X101 13F (30d) 461 filings 408 filers Visit website Investor relations